C-reactive protein correlates with tissue oxygen availability in patients with stable COPD

International Journal of COPD

Volumn 3, Issue 4, 2008, Pages 745-751

  Baldi, Simonetta ^a   Pinna, Gian Domenico ^a   Mombaruzzo, Piera ^a   Biglieri, Milena ^a   De Martini, Angelo ^a   Palange, Paolo ^b  

^a IRCCS   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

C reactive protein; COPD; Oxygen extractivity; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN AFFINITY; OXYGEN CONSUMPTION; OXYGEN TISSUE LEVEL; OXYGEN TRANSPORT; PREDICTION; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE DISTRIBUTION; TISSUE OXYGENATION;

AGED; AGED, 80 AND OVER; ANOXIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARBOXYHEMOGLOBIN; FEMALE; HEMOGLOBINS; HUMANS; INFLAMMATION MEDIATORS; LINEAR MODELS; MALE; METHEMOGLOBIN; MIDDLE AGED; OXYGEN; OXYHEMOGLOBINS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 60249098083     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Agustí AGN, Noguera A, Sauleda J, et al. 2003. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J, 21:347-60.
2. [ATS] American Thoracic Society. 1995. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique-1995 update. Am J Respir Crit Care Med, 152:2185-98.
3. Broekhuizen R, Wouters EFM, Creutzberg EC, et al. 2006. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax, 61:17-22.
4. Burrows B, Kettel LJ, Niden AH, et al. 1972. Patterns of cardiovascular dysfunction in chronic obstructive lung disease. N Engl J Med, 27:912-8.
5. Celli BR, Cote CG, Marin JM, et al. 2004. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 350:1005-12.
6. Chance B, Leigh JS, Kent J, et al. 1986. Multiple controls of oxidative metabolism in living tissue as studied by phosphorus magnetic resonance. Proc Natl Acad Sci U S A, 83:9458-62.
7. Cotes JE. 1979. Lung function: assessment and application in medicine. 4th ed. Oxford: Blackwell Scientific Publications.
8. de Torres JP, Cordoba-Lanus E, López-Aguilar C, et al. 2006. C-Reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J, 27:902-7.
9. Engelen MP, Schols AM, Does JD, et al. 2000. Exercise-induced lactate increase in relation to muscles substrates in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 162:1697-704.
10. Filley GF, Beckwitt HJ, Reeves JT, et al. 1968. Chronic obstructive bronchopulmonary disease. II. Oxygen transport in the two clinical types. Am J Med, 44:26-38.
11. Gan WQ, Man SFP, Senthilselvan A, et al. 2004. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and meta-analysis. Thorax, 59:574-80.
12. Ghezzi P, Dinarello CA, Bianchi M, et al. 1991. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine, 3:189-94.
13. Gonzalez-Alonso J, Mortensen S, Dawson EA, et al. 2006. Erythrocytes and the regulation of human skeletal muscle blood flow and oxygen delivery: role of erythrocyte count and oxygenation state of hemoglobin. J Physiol, 572:295-305.
14. Hagobian TA, Jacobs KA, Subudhi AW, et al. 2006. Cytokine response at high altitude: effects of exercise and antioxidants at 4300 m. Med Sci Sports Exerc, 38:276-85.
15. Hartmann G, Tschöp M, Fischer R, et al. 2000. High altitude increases circulating Interleukin-6, Interleukin-1 receptor antagonist and C-reactive protein. Cytokine, 12:246-52.
16. Jakobsson P, Jarfeld L, Brundin A. 1990. Skeletal muscles metabolites and fiber types in patients with advanced chronic obstructive pulmonary disease. Eur Respir J, 3:192-6.
17. Kawakami Y, Kishi F, Yamamoto H, et al. 1983. Relation of oxygen delivery, mixed venous oxygenation, and pulmonary hemodynamics to prognosis in chronic obstructive pulmonary disease. N Engl J Med, 308:1405-7.
18. Keller C, Steenberg A, Pilegaard H, et al. 2001. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J, 15:2748-50.
19. Kishimoto T. 1989. The biology of interleukin-6. Blood, 74:1-10.
20. Maltais F, Simard AA, Simard C, et al. 1996. Oxydative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med, 153:288-93.
21. Pauwels RA, Buist S, Calverley PM, et al. 2001. GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med, 163:1256-76.
22. Pinto-Plata VM, Müllerova H, Toso JF, et al. 2006. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax, 6:23-8.
23. Quanjer PH, Tammeling GJ, Cotes JE, et al. 1993. Standardized lung function testing. Eur Respir J, 6:5-40.
24. 2 but lack of correlation between 'the oxygen compensation factor' and cardiac output in 38 patients. Scand J Clin Lab Invest Suppl, 203:67-73.
25. Sauleda J, Garcia-Palmer F, Wiesner RJ, et al. 1998. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 157(5 Pt 1):1413-7.
26. Schols AM, Buurma WA, Staal van den Brekel AJ, et al. 1996. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax, 51:819-24.
27. Semenza GL. 2000. HIF-1 factor: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol, 88:1474-80.
28. Siggard-Andersen M, Siggard-Andersen O. 1990. The Oxygen status algorithm: a computer program for calculating and displaying pH, blood gas data. Scand J Clin Lab Invest, 59(Suppl 203):29-45.
29. Siggaard-Andersen O, Wimberley PD, Gøthgen IH, et al. 1984. A mathematical model of the hemoglobin-oxygen dissociation curve of human blood and of the oxygen partial pressure as a function of temperature. Clin Chem, 30:1646-51.
30. Siggard-Andersen O, Fogh-Andersen N, Gøthgen IH, et al. 1995. Oxygen status of arterial and mixed venous blood. Crit Care Med, 23:1284-93.
31. Takabatake N, Nakamura H, Abe S, et al. 2000. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-α system in patients with chronic obstructive pulmonary disease. Am J Rev Crit Care Med, 161:1179-84.
32. Wouters EFM. 2005. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2:26-33.
33. Yokoe T, Minoguchi K, Matsuo H, et al. 2003. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation, 107:1129-34.
34. Yu AY, Frid MG, Shimoda LA, et al. 1998. Temporal, spatial and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol Lung Cell Mol Physiol, 275:L818-L26.